Navigation Links
Shengtai Pharmaceutical, Inc. to Present at Roth Conference
Date:2/7/2008

WEIFANG, China, Feb. 7 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai Pharmaceutical" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today announced its CFO, Mr. Yizhao Zhang, will present at the upcoming Roth 20th Annual OC Growth Stock Conference in Dana Point, California.

The date, time and location of Shengtai Pharmaceutical, Inc.'s presentation at the conference are as follows:

Date: Thursday, February 21, 2008

Time: 10:30 a.m. Pacific Time

Venue: Ritz Ballroom Salon 1

The Ritz Carlton Laguna Niguel

One Ritz-Carlton Drive

Dana Point, California 92629

Webcast: http://www.wsw.com/webcast/roth16/sgti/

A replay of the call will be available for 90 days following the presentation using the same link and will also be available on the Company's website.

The ROTH 20th Annual OC Conference will feature presentations from over 300 small-cap companies including over 40 U.S.-listed Chinese companies. The distinguished list of presenting companies have been identified by Roth Capital's award-winning research team and are representative of a broad spectrum of sectors, including Technology, Healthcare, Energy and Industrial as well as Consumer Products.

Interested parties and investors may find more information for the conference by visiting the website at http://www.rothcapital.com.

About Shengtai Pharmaceutical, Inc.

Shengtai Pharmaceutical, Inc. through its wholly-owned subsidiary Shengtai Holding, Inc. (SHI), a New Jersey corporation, and the holding company for Weifang Shengtai Pharmaceutical Co., Ltd., is a leading manufacturer and supplier of glucose products, which include pharmaceutic
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Shengtai Pharmaceutical, Inc. to Present at Roth Capital Phoenix Conference
2. Shengtai Pharmaceutical, Inc. Reports First Quarter Results of Fiscal Year 2008
3. Shengtai Pharmaceutical, Inc. Reports Record 2007 Annual Results
4. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
5. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
6. 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference to Webcast Millennium Presentation
7. Cardinal Health CEO of Clinical & Medical Products to Speak at Merrill Lynchs Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
9. MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
11. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... (PRWEB) May 05, 2015 The ... for assessing and treating children with feeding and ... the course of 20 years through the clinical ... Kay Toomey , in conjunction with colleagues from ... dieticians, and speech pathologists. Education Resources Inc. is ...
(Date:5/5/2015)... NJ (PRWEB) May 05, 2015 Texting has ... is no surprise that some physicians text as a way ... we urge providers who are doing so to assure medical ... does not come without risk! When providers transmit protected ... mobile devices, they run the risk of violating the Health ...
(Date:5/5/2015)... Curly Hair Solutions™ is delighted to introduce the ... Mist. The collection has every curl type covered, ... loose to medium body curls is exposure to the ocean ... fancying the ocean breeze needn’t leave their bathroom. , ... Mist produces the same invigorating freshness one gets when exposed ...
(Date:5/5/2015)... MA (PRWEB) May 05, 2015 Lauren ... goods retailer City Sports , was named one ... and active lifestyle industry by the SportsOneSource ... , Ms. Blanda, 33, is one of 40 executives ... Sporting Goods Business magazine) recognized for exceptional achievement in ...
(Date:5/4/2015)... Parlin dentist, Dr Mariana Blagoev is extending her ... to participate and win a laptop. , Dr. Blagoev created ... good deeds and share them on her Facebook page. By ... teach them to be kind and compassionate when they mature ... years of age and under. Youths are urged to submit ...
Breaking Medicine News(10 mins):Health News:Commission on Dietetic Registration Approves Two Pediatric Feeding Courses Offered by Education Resources Inc. 2Health News:HIPAA Compliant Texting Service from MedXcom now available for Policyholders 2Health News:Curly Hair Solutions Introduces New Revolutionary Product: Curl Keeper Beach Mist 2Health News:Sporting Goods Trade Group Names City Sports’ Lauren Blanda to Its Annual “40 Under 40” List 2Health News:Sporting Goods Trade Group Names City Sports’ Lauren Blanda to Its Annual “40 Under 40” List 3Health News:10 More Days To Enter Good Deed Contest 2
... a connection with obesity risks as they grow up, more so, in ... team of researchers led by Sarah E. Anderson, M.S., from Tufts University ... and 417 men - who underwent assessment four times between 1983 and ... during the beginning of the study, and were in the age group ...
... deteriorate as they progress through puberty, reveals a new ... levels of insulin, however, remain unchanged in their Caucasian ... plays a crucial role in determining the individual risk ... study was conducted by Dr. Geoff Ball and his ...
... Ramadoss said that India is crowned as the diabetic capital. ... national programme for prevention and control of cardiovascular disease, //stroke ... meeting. ,He submitted a draft of the programme ... to make it workable. ,The programme’s main ...
... global network of virus, spyware and spam analysis centers, have warned ... across the internet.// ,This letter claims that lipstick causes ... contain a dangerously high level of lead which can cause cancer. ... claims are not true. ,Sopho has asked the users ...
... incidence of pregnancy complications, more specifically preeclampsia related//, ... Obstetrics and Gynecology. ,Preeclampsia, a pregnancy-related ... (high levels of protein in the urine). Swelling ... seen. If left unattended, the condition can worsen ...
... the women especially the pregnant women about the risks ... as selective serotonin re-uptake inhibitors //(SSRIs) affect the fetus. ... called persistent pulmonary hypertension in babies born to women ... The recent study links SSRIs to this fatal condition ...
Cached Medicine News:Health News:African American Children More Pone to Develop Diabetes 2
(Date:5/4/2015)... 2015 RadiologyAuction will have their first auction starting ... demonstrations at the end of the auction on May ... and Fuji Cr,s, Agfa and Sony, printers and GE ... Various imaging equipment will be available at later auctions ... years of buying and selling imaging equipment, the brokers ...
(Date:5/4/2015)... , May 4, 2015 PharmaEngine, ... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) with ... BAX ) jointly announced that Baxter has submitted ... Medicines Agency (EMA) for MM-398 (irinotecan liposome injection), ... adenocarcinoma of the pancreas who have been previously ...
(Date:5/4/2015)... May 4, 2015  Makindus, Inc. a specialty pharmaceutical ... European Medicines Agency (EMA) has granted orphan drug designation ... Stargardt,s Disease. "We are extremely pleased to ... Stargardt,s disease in place for Europe ... the United States for which ...
Breaking Medicine Technology:RadiologyAuction Announces Event Starting On May 5th 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2
... GRASS VALLEY, Calif., Jan. 18, 2011 Eigen, a ... announced the completion of the company,s restructuring plan designed ... billion urology medical device marketplace. The company ... is now positioned with a unified management team and ...
... 2011 Vasomedical, Inc. ("Vasomedical") (OTC Bulletin Board: ... today announced financial results of the three months ended ... the noninvasive treatment of cardiovascular diseases. In addition, the ... VasoHealthcare , commenced operations on July 1, 2010 under ...
Cached Medicine Technology:Vasomedical Reports Financial Results for the Quarter Ended November 30, 2010 2Vasomedical Reports Financial Results for the Quarter Ended November 30, 2010 3Vasomedical Reports Financial Results for the Quarter Ended November 30, 2010 4
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
The design of the new ChloraPrep swabstick applicator provides significant improvement in performance over traditional swabsticks....
... Swabsticks are packaged in easy open, single-use ... saturated with precisely the correct amount of ... the safest possible product for the patient. ... an excellent combination of ethyl alcohol and ...
... provides 5% povidone-iodine solution ... It delivers a microbicidal ... tender to touch. It ... indicated whenever effective microbicidal ...
Medicine Products: